Thus, this study is the first to describe the AC005332.1& AC012615.1/hsa-miR-100-5p/ORAOV1 regulatory axis in HCC, providing novel insight into the molecular pathogenesis of this disease. The gene discussed is LTO1; the disease is hepatocellular carcinoma.